Vladimir Oykhman, MD
General Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 54 years
- Graduated 1972
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Oykhman’s office at (408) 871-3400 to ask if they take your plan before you enroll.
California Medical Board record
Licence A39980 · Current
Licensed to practise in California · since 1983 · expires 2028-08-31 · Military Medical Academy, Leningrad.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$74,288
Medicare paid this office $74,288 for 447 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 249 | $27,396 | $81 |
| Return visit (30+ min) | 207 | $26,827 | $108 |
| Injection of trigger points, 1-2 muscles | 64 | $3,432 | $41 |
| Short return visit | 25 | $2,625 | $57 |
| New patient visit (30+ min) | 21 | $1,931 | $92 |
See all 11 services
| Short return visit (20+ min) | 249 | $27,396 | $81 |
| Return visit (30+ min) | 207 | $26,827 | $108 |
| Injection of trigger points, 1-2 muscles | 64 | $3,432 | $41 |
| Short return visit | 25 | $2,625 | $57 |
| New patient visit (30+ min) | 21 | $1,931 | $92 |
| Aspiration and/or injection of fluid from large joint | 25 | $1,839 | $59 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 26 | $1,307 | $50 |
| Removal of impacted ear wax | 16 | $593 | $37 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 91 | $477 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 26 | $287 | $11 |
| Urinalysis, manual test | 63 | $225 | $3 |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of trigger points, 1-2 muscles | 82 | 66 | 73 | 87 | 87 | 84 |
| Aspiration and/or injection of fluid from large joint | 15 | – | 26 | 28 | 40 | 31 |
| Injection into tendon at attachment to bone or muscle | – | 13 | 13 | – | – | – |
| Aspiration and/or injection of fluid from small joint | 13 | – | 13 | – | – | – |
| Removal of impacted ear wax | – | – | – | – | – | 16 |
| Injection into tendon or ligament | 15 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
447 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 21% · Women 63% · Also on Medicaid 9% · Health risk score 1.12. At or below the middle of the specialty; the typical general practice clinician is at 1.33.
Conditions among them: High blood pressure 75% · Diabetes 29% · Coronary heart disease 23% · Chronic kidney disease 21% · Depression 19% · Cancer 17% · Atrial fibrillation 17% · Heart failure 15% · COPD 11% · Stroke 8% · Dementia 4%.
The office billed $320,249, Medicare allowed $104,124 and paid $74,288; for 2,224 services of 64 kinds; $984 of it was for drugs given in the office and $73,304 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 447 | 2,224 | 76 | 1.12 | $320,249 | $74,288 |
| 2023 | 390 | 1,891 | 77 | 1.15 | $300,926 | $73,598 |
| 2022 | 381 | 1,707 | 77 | 1.08 | $279,543 | $65,573 |
| 2021 | 405 | 1,415 | 76 | 1.17 | $226,903 | $59,716 |
| 2020 | 241 | 1,109 | 76 | 1.23 | $148,259 | $33,511 |
| 2019 | 341 | 1,281 | 76 | 1.22 | $198,659 | $47,678 |
| 2018 | 321 | 1,468 | 75 | 1.19 | $205,329 | $46,974 |
| 2017 | 355 | 1,480 | 75 | 1.31 | $185,023 | $48,000 |
| 2016 | 390 | 1,490 | 75 | 1.29 | $190,122 | $48,005 |
| 2015 | 285 | 2,080 | 75 | 1.27 | $189,639 | $57,023 |
| 2014 | 320 | 2,327 | 74 | 1.06 | $199,467 | $61,562 |
| 2013 | 265 | 1,734 | 75 | 1.25 | $107,159 | $47,097 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 215 | $31,201 | $115 |
| Short return visit (20+ min) | 166 | $20,450 | $84 |
| Injection of trigger points, 1-2 muscles | 58 | $3,804 | $44 |
| New patient visit (30+ min) | 29 | $2,704 | $93 |
| Aspiration and/or injection of fluid from large joint | 31 | $2,394 | $60 |
| Short return visit | 23 | $1,700 | $50 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 94 | $614 | None |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 12 | $603 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 35 | $446 | $12 |
| Injection of drug or substance under skin or into muscle | 11 | $315 | $14 |
| Urinalysis, manual test | 65 | $259 | $3 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | $211 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $121 | $10 |
| Blood glucose (sugar) test performed by hand-held instrument | 14 | $48 | $3 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 11 | $1 | None |
2022: 12 services
| Return visit (30+ min) | 197 | $27,858 | $115 |
| Short return visit (20+ min) | 161 | $14,711 | $75 |
| Injection of trigger points, 1-2 muscles | 62 | $3,935 | $45 |
| Long return visit (40+ min) | 21 | $3,525 | $168 |
| New patient visit (30+ min) | 26 | $2,184 | $84 |
| Short return visit | 31 | $1,851 | $47 |
| Aspiration and/or injection of fluid from large joint | 27 | $1,762 | $63 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 92 | $642 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 39 | $485 | $12 |
| Urinalysis, manual test | 56 | $227 | $3 |
| Administration of vaccine | 11 | $155 | $14 |
| Blood glucose (sugar) test performed by hand-held instrument | 21 | $81 | $3 |
2021: 13 services
| Return visit (30+ min) | 186 | $26,021 | $120 |
| Short return visit (20+ min) | 130 | $12,927 | $80 |
| Injection of trigger points, 1-2 muscles | 51 | $3,303 | $45 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 79 | $2,613 | $30 |
| Long return visit (40+ min) | 13 | $2,271 | $175 |
| New patient visit (30+ min) | 19 | $1,951 | $103 |
| Short return visit | 24 | $1,830 | $51 |
| Aspiration and/or injection of fluid from large joint | 21 | $1,469 | $56 |
| Injection into tendon at attachment to bone or muscle | 11 | $684 | $53 |
| Aspiration and/or injection of fluid from small joint | 12 | $618 | $48 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 80 | $547 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 33 | $490 | $14 |
| Urinalysis, manual test | 36 | $132 | $3 |
2020: 9 services
| Return visit (30+ min) | 141 | $12,328 | $82 |
| Short return visit (20+ min) | 86 | $7,827 | $66 |
| Injection of trigger points, 1-2 muscles | 52 | $2,853 | $43 |
| Short return visit | 22 | $1,714 | $44 |
| New patient visit (30+ min) | 13 | $1,361 | $105 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | $531 | None |
| Injection into tendon at attachment to bone or muscle | 11 | $382 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $262 | $13 |
| Urinalysis, manual test | 24 | $90 | $3 |
2019: 15 services
| Return visit (30+ min) | 206 | $21,329 | $91 |
| Short return visit (20+ min) | 115 | $9,206 | $64 |
| Injection of trigger points, 1-2 muscles | 55 | $3,998 | $49 |
| Long return visit (40+ min) | 16 | $2,076 | $130 |
| New patient visit (45+ min) | 12 | $1,600 | $133 |
| New patient visit (30+ min) | 13 | $1,137 | $87 |
| Short return visit | 17 | $1,106 | $43 |
| Aspiration and/or injection of fluid from large joint | 14 | $824 | $55 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $590 | None |
| Injection into tendon or ligament | 12 | $473 | $32 |
| Aspiration and/or injection of fluid from small joint | 11 | $441 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $402 | $14 |
| Injection of drug or substance under skin or into muscle | 11 | $199 | $17 |
| Removal of impacted ear wax by washing | 13 | $159 | $12 |
| Urinalysis, manual test | 21 | $82 | $3 |
2018: 17 services
| Return visit (30+ min) | 193 | $18,731 | $85 |
| Short return visit (20+ min) | 99 | $8,295 | $61 |
| Long return visit (40+ min) | 29 | $3,657 | $122 |
| Injection of trigger points, 1-2 muscles | 46 | $3,624 | $50 |
| New patient visit (45+ min) | 14 | $1,860 | $133 |
| New patient visit (30+ min) | 12 | $996 | $83 |
| Short return visit | 22 | $930 | $37 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $822 | None |
| Injection into tendon or ligament | 16 | $679 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 40 | $598 | $14 |
| Injection of drug or substance under skin or into muscle | 14 | $404 | $20 |
| Administration of vaccine | 11 | $202 | $18 |
| Evaluation of use of breathing device | 14 | $184 | $13 |
| Removal of impacted ear wax by washing | 11 | $169 | $15 |
| Urinalysis, manual test | 16 | $55 | $3 |
| Infusion, normal saline solution , 1000 cc | 12 | $22 | None |
| Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 15 | $2 | None |
2017: 16 services
| Return visit (30+ min) | 230 | $22,030 | $84 |
| Short return visit (20+ min) | 95 | $6,013 | $57 |
| Long return visit (40+ min) | 26 | $3,311 | $123 |
| Injection of trigger points, 1-2 muscles | 42 | $2,535 | $49 |
| New patient visit (45+ min) | 15 | $1,747 | $116 |
| New patient visit (30+ min) | 17 | $1,335 | $79 |
| Infusion into a vein for hydration, 31-60 minutes | 13 | $732 | $56 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 58 | $695 | None |
| Short return visit | 15 | $653 | $38 |
| Injection of drug or substance under skin or into muscle | 18 | $590 | $21 |
| Injection into tendon or ligament | 14 | $577 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 33 | $433 | $13 |
| Removal of impacted ear wax by washing | 11 | $158 | $14 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $149 | $14 |
| Urinalysis, manual test | 12 | $41 | $3 |
| Infusion, normal saline solution , 1000 cc | 11 | $18 | None |
2016: 17 services
| Return visit (30+ min) | 236 | $21,049 | $82 |
| Short return visit (20+ min) | 98 | $7,095 | $55 |
| Injection of trigger points, 1-2 muscles | 37 | $2,628 | $47 |
| New patient visit (45+ min) | 21 | $2,557 | $122 |
| New patient visit (30+ min) | 30 | $2,418 | $81 |
| Long return visit (40+ min) | 15 | $1,820 | $121 |
| Infusion into a vein for hydration, 31-60 minutes | 20 | $1,131 | $57 |
| Injection into tendon or ligament | 17 | $1,007 | $53 |
| Injection of drug or substance under skin or into muscle | 17 | $791 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 55 | $694 | None |
| Short return visit | 18 | $681 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 45 | $677 | $15 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $224 | $17 |
| Blood glucose (sugar) test performed by hand-held instrument | 13 | $44 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 12 | $40 | None |
| Infusion, normal saline solution , 1000 cc | 24 | $38 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 11 | $0 | None |
2015: 14 services
| Return visit (30+ min) | 160 | $18,084 | $99 |
| Short return visit (20+ min) | 113 | $13,986 | $68 |
| Injection of trigger points, 1-2 muscles | 67 | $6,269 | $52 |
| New patient visit (45+ min) | 34 | $4,682 | $138 |
| Injection into tendon or ligament | 27 | $1,873 | $62 |
| New patient visit (30+ min) | 17 | $1,543 | $91 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 98 | $1,432 | None |
| Aspiration and/or injection of fluid from small joint | 23 | $1,214 | $40 |
| Short return visit | 14 | $617 | $41 |
| Injection of drug or substance under skin or into muscle | 11 | $586 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $273 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $194 | $16 |
| Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 11 | $2 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 11 | $1 | None |
2014: 11 services
| Return visit (30+ min) | 153 | $18,051 | $97 |
| Short return visit (20+ min) | 154 | $15,325 | $63 |
| Injection of trigger points, 1-2 muscles | 96 | $8,720 | $49 |
| New patient visit (30+ min) | 45 | $3,736 | $83 |
| New patient visit (45+ min) | 17 | $2,250 | $132 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,878 | $55 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 121 | $1,837 | None |
| Injection into tendon or ligament | 28 | $1,650 | $52 |
| Aspiration and/or injection of fluid from small joint | 15 | $1,153 | $48 |
| Short return visit | 12 | $571 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $368 | $15 |
2013: 12 services
| Short return visit (20+ min) | 142 | $15,371 | $66 |
| Return visit (30+ min) | 59 | $5,776 | $95 |
| New patient visit (30+ min) | 59 | $5,279 | $89 |
| Injection of trigger points, 1-2 muscles | 70 | $5,266 | $49 |
| New patient visit (45+ min) | 21 | $3,042 | $145 |
| Aspiration and/or injection of fluid from large joint | 21 | $1,883 | $59 |
| Short return visit | 28 | $1,342 | $39 |
| Injection into tendon or ligament | 18 | $1,340 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 90 | $1,189 | None |
| Injection of drug or substance under skin or into muscle | 15 | $593 | $25 |
| Aspiration and/or injection of fluid from small joint | 13 | $565 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $319 | $17 |
Drugs they prescribed that Part D paid
$16,850
Pharmacies billed $16,850 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (54 of 736) in 2024. A higher opioid share than 9 in 10 peers; the typical general practice clinician is at 0%.
695 generic and 41 brand-name prescriptions · $16,850 in drug cost · 293 antibiotic prescriptions to 256 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tobramycin-Dexamethasone | 15 | $1,393 | $93 |
| Celecoxib | 12 | $794 | $66 |
| Neomycin-Polymyxin-Hydrocort | 16 | $657 | $41 |
| Baclofen | 68 | $655 | $10 |
| Doxycycline Hyclate | 81 | $615 | $8 |
See all 18 drugs
| Tobramycin-Dexamethasone | 15 | $1,393 | $93 |
| Celecoxib | 12 | $794 | $66 |
| Neomycin-Polymyxin-Hydrocort | 16 | $657 | $41 |
| Baclofen | 68 | $655 | $10 |
| Doxycycline Hyclate | 81 | $615 | $8 |
| Albuterol Sulfate Hfa | 27 | $526 | $19 |
| Fluocinonide | 13 | $447 | $34 |
| Cephalexin | 66 | $395 | $6 |
| Hydrocodone-Acetaminophen | 47 | $295 | $6 |
| Amoxicillin-Clavulanate Potass | 34 | $225 | $7 |
| Naproxen | 28 | $205 | $7 |
| Mometasone Furoate | 12 | $164 | $14 |
| Sulfamethoxazole-Trimethoprim | 32 | $137 | $4 |
| Azithromycin | 34 | $125 | $4 |
| Losartan-Hydrochlorothiazide | 11 | $101 | $9 |
| Furosemide | 14 | $85 | $6 |
| Methylprednisolone | 13 | $66 | $5 |
| Ciprofloxacin | 13 | $56 | $4 |
Year by year
| 2024 | 736 | 438 | 7% (54) | 6% | $16,850 |
| 2023 | 693 | 393 | 11% (76) | None | $30,403 |
| 2022 | 553 | 337 | 11% (58) | None | $15,156 |
| 2021 | 549 | 312 | 12% (65) | None | $18,475 |
| 2020 | 383 | 240 | 12% (44) | 13% | $12,798 |
| 2019 | 521 | 341 | 8% (44) | 12% | $14,537 |
| 2018 | 530 | 337 | 12% (61) | 13% | $18,637 |
| 2017 | 518 | 306 | 9% (48) | None | $19,729 |
| 2016 | 493 | 274 | 17% (82) | 12% | $15,801 |
| 2015 | 502 | 255 | 18% (92) | 13% | $22,573 |
| 2014 | 469 | 261 | 27% (126) | None | $17,674 |
| 2013 | 443 | 238 | 30% (132) | 16% | $14,510 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Doxycycline Hyclate | 111 | $2,252 | $20 |
| Fluocinonide | 17 | $1,240 | $73 |
| Tobramycin-Dexamethasone | 13 | $1,192 | $92 |
| Baclofen | 56 | $897 | $16 |
| Hydrocodone-Acetaminophen | 69 | $519 | $8 |
| Cephalexin | 53 | $459 | $9 |
| Amoxicillin-Clavulanate Potass | 19 | $252 | $13 |
| Nitrofurantoin Mono-Macro | 11 | $231 | $21 |
| Ciprofloxacin | 19 | $196 | $10 |
| Amlodipine Besylate | 14 | $137 | $10 |
| Methylprednisolone | 14 | $136 | $10 |
| Naproxen | 18 | $128 | $7 |
| Furosemide | 14 | $115 | $8 |
| Azithromycin | 22 | $107 | $5 |
| Levofloxacin | 11 | $89 | $8 |
2022: 15 drugs
| Doxycycline Hyclate | 69 | $1,570 | $23 |
| Fluocinonide | 22 | $1,549 | $70 |
| Baclofen | 48 | $1,085 | $23 |
| Losartan-Hydrochlorothiazide | 17 | $611 | $36 |
| Cephalexin | 57 | $468 | $8 |
| Valacyclovir | 11 | $422 | $38 |
| Hydrocodone-Acetaminophen | 53 | $391 | $7 |
| Tizanidine | 15 | $196 | $13 |
| Metronidazole | 11 | $191 | $17 |
| Metoprolol | 11 | $187 | $17 |
| Amoxicillin-Clavulanate Potass | 15 | $182 | $12 |
| Ciprofloxacin | 16 | $125 | $8 |
| Naproxen | 11 | $98 | $9 |
| Azithromycin | 11 | $61 | $6 |
| Amlodipine Besylate | 14 | $59 | $4 |
2021: 13 drugs
| Baclofen | 60 | $1,314 | $22 |
| Fluocinonide | 14 | $1,130 | $81 |
| Doxycycline Hyclate | 40 | $901 | $23 |
| Hydrocodone-Acetaminophen | 56 | $471 | $8 |
| Cephalexin | 54 | $415 | $8 |
| Allopurinol | 12 | $180 | $15 |
| Naproxen | 20 | $157 | $8 |
| Ciprofloxacin | 22 | $143 | $7 |
| Dicyclomine | 13 | $130 | $10 |
| Methylprednisolone | 11 | $90 | $8 |
| Omeprazole | 11 | $90 | $8 |
| Losartan | 13 | $68 | $5 |
| Amlodipine Besylate | 15 | $59 | $4 |
2020: 6 drugs
| Baclofen | 54 | $1,230 | $23 |
| Doxycycline Hyclate | 35 | $899 | $26 |
| Hydrocodone-Acetaminophen | 42 | $330 | $8 |
| Cephalexin | 39 | $317 | $8 |
| Amoxicillin-Clavulanate Potass | 15 | $183 | $12 |
| Azithromycin | 15 | $110 | $7 |
2019: 11 drugs
| Doxycycline Hyclate | 48 | $1,024 | $21 |
| Baclofen | 46 | $893 | $19 |
| Fluocinonide | 14 | $748 | $53 |
| Ventolin Hfa | 13 | $732 | $56 |
| Azithromycin | 55 | $492 | $9 |
| Amoxicillin-Clavulanate Potass | 30 | $431 | $14 |
| Cephalexin | 39 | $291 | $7 |
| Hydrocodone-Acetaminophen | 36 | $266 | $7 |
| Levofloxacin | 18 | $225 | $13 |
| Methylprednisolone | 14 | $204 | $15 |
| Amlodipine Besylate | 13 | $169 | $13 |
2018: 12 drugs
| Tobramycin-Dexamethasone | 13 | $1,741 | $134 |
| Proair Hfa | 25 | $1,543 | $62 |
| Baclofen | 65 | $1,521 | $23 |
| Doxycycline Hyclate | 46 | $1,414 | $31 |
| Fluocinonide | 11 | $585 | $53 |
| Amoxicillin-Clavulanate Potass | 32 | $502 | $16 |
| Hydrocodone-Acetaminophen | 44 | $305 | $7 |
| Cephalexin | 36 | $300 | $8 |
| Azithromycin | 32 | $250 | $8 |
| Levofloxacin | 17 | $146 | $9 |
| Ciprofloxacin | 13 | $144 | $11 |
| Tramadol | 11 | $85 | $8 |
2017: 10 drugs
| Tobramycin-Dexamethasone | 16 | $2,135 | $133 |
| Proair Hfa | 30 | $1,747 | $58 |
| Baclofen | 60 | $1,144 | $19 |
| Doxycycline Hyclate | 23 | $669 | $29 |
| Amoxicillin-Clavulanate Potass | 29 | $378 | $13 |
| Nitrofurantoin Mono-Macro | 11 | $248 | $23 |
| Doxycycline Monohydrate | 20 | $208 | $10 |
| Azithromycin | 35 | $199 | $6 |
| Hydrocodone-Acetaminophen | 35 | $191 | $5 |
| Cephalexin | 29 | $165 | $6 |
2016: 12 drugs
| Baclofen | 61 | $1,300 | $21 |
| Proair Hfa | 17 | $942 | $55 |
| Hydrocodone-Acetaminophen | 57 | $563 | $10 |
| Nitrofurantoin Mono-Macro | 16 | $489 | $31 |
| Metoprolol | 14 | $432 | $31 |
| Doxycycline Hyclate | 12 | $303 | $25 |
| Doxycycline Monohydrate | 17 | $205 | $12 |
| Amoxicillin-Clavulanate Potass | 13 | $203 | $16 |
| Azithromycin | 31 | $182 | $6 |
| Ciprofloxacin | 13 | $102 | $8 |
| Alprazolam | 11 | $37 | $3 |
| Meloxicam | 11 | $36 | $3 |
2015: 11 drugs
| Baclofen | 81 | $1,668 | $21 |
| Proair Hfa | 15 | $767 | $51 |
| Hydrocodone-Acetaminophen | 54 | $589 | $11 |
| Doxycycline Hyclate | 11 | $438 | $40 |
| Doxycycline Monohydrate | 15 | $303 | $20 |
| Azithromycin | 31 | $222 | $7 |
| Montelukast | 18 | $196 | $11 |
| Levofloxacin | 12 | $149 | $12 |
| Amoxicillin-Clavulanate Potass | 12 | $148 | $12 |
| Tramadol | 20 | $130 | $7 |
| Ciprofloxacin | 13 | $74 | $6 |
2014: 7 drugs
| Doxycycline Hyclate | 28 | $1,494 | $53 |
| Hydrocodone-Acetaminophen | 67 | $1,182 | $18 |
| Baclofen | 50 | $621 | $12 |
| Oxycodone-Acetaminophen | 23 | $515 | $22 |
| Azithromycin | 25 | $201 | $8 |
| Ciprofloxacin | 29 | $190 | $7 |
| Tramadol | 20 | $163 | $8 |
2013: 8 drugs
| Doxycycline Hyclate | 25 | $1,251 | $50 |
| Hydrocodone-Acetaminophen | 73 | $724 | $10 |
| Amox Tr-Potassium Clavulanate | 14 | $355 | $25 |
| Tramadol | 32 | $277 | $9 |
| Oxycodone Hcl-Acetaminophen | 12 | $200 | $17 |
| Ciprofloxacin | 20 | $145 | $7 |
| Azithromycin | 15 | $138 | $9 |
| Amlodipine Besylate | 15 | $84 | $6 |
Money from drug and device companies
$284 in 2023
A payment is not proof that care is biased.
| Si-Bone | None | $150 | 1 payment
|
| GlaxoSmithKline | Shingrix | $110 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $24 | 1 payment
|
See all 4 published payments
| Exact Sciences | Meals · 2023-12-12 | Cologuard Collection Kit | $24 |
| Si-Bone | Meals · 2023-05-18 | None | $150 |
| GlaxoSmithKline | Meals · 2023-01-25 | Shingrix | $19 |
| GlaxoSmithKline | Meals · 2023-01-25 | Shingrix | $91 |
Professional record
- NPI
- 1861503401
- Licence
- CA A39980California A39980: Current · expires 2028-08-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A399800
- Taxonomy
- General practice (208D00000X)
- Mailing address
- 625 Lincoln Ave, San Jose, CA, 95126
- NPI first listed
- 2006-08-31
- NPI last updated
- 2020-12-04
- NPI record certified
- 2020-12-04
This is when the NPI record was last certified, not a medical board exam.